STOCK TITAN

Leonardo DRS, Inc. SEC Filings

DRS NASDAQ

Welcome to our dedicated page for Leonardo DRS SEC filings (Ticker: DRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Leonardo DRS, Inc. (Nasdaq: DRS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Leonardo DRS is a defense technology company headquartered in Arlington, Virginia, with common stock registered under Section 12(b) of the Exchange Act and listed on The Nasdaq Stock Market LLC under the symbol DRS.

Through this page, users can review Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s two primary segments, Advanced Sensing and Computing and Integrated Mission Systems, along with risk factors, contract information and financial results. Form 8-K current reports document material events such as leadership transitions, board changes, earnings releases and other significant corporate developments, including updates to executive employment agreements and conference call announcements.

Investors interested in ownership and governance details can also look for proxy statements and related filings that discuss board composition and committee responsibilities. In addition, Form 4 insider transaction reports, when available, show purchases and sales of DRS common stock by directors, officers and other insiders.

Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand segment performance, major contracts in areas like advanced sensing, network computing, force protection, and electric power and propulsion, and notable changes in leadership or governance. Real-time updates from EDGAR ensure that new Leonardo DRS filings, including earnings-related 8-Ks and other disclosures, are added as they become available, giving users a structured view of the company’s regulatory history and ongoing reporting obligations.

Rhea-AI Summary

Leonardo DRS, Inc. executive vice president and chief financial officer Michael Dippold reported selling 10,588 shares of common stock on January 5, 2026 at $37 per share. After this transaction, he directly held 42,952 shares of Leonardo DRS common stock. The filing notes that these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025, which is designed to allow insiders to sell shares according to a preset schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Leonardo DRS, Inc. filed an Amendment No. 1 to its quarterly report for the period ended September 30, 2025 to add information that was inadvertently omitted about an executive stock trading plan. The amendment updates the section on securities trading plans to disclose that Executive Vice President Operations Sally A. Wallace adopted a Rule 10b5-1 trading arrangement on August 6, 2025 covering up to 38,987 shares of common stock, with a scheduled expiration date of October 30, 2026. As of October 28, 2025, the company had 266,026,725 shares of common stock outstanding. The company states that no financial statements or other disclosures from the original quarterly report are being changed by this amendment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
quarterly report
-
Rhea-AI Summary

Leonardo DRS received a notice under Rule 144 for a planned sale of restricted stock. An affiliated holder plans to sell 1,300 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $45,721.00.

The shares were acquired on 11/29/2024 through restricted stock vesting as compensation from the issuer. The notice lists 266,026,725 common shares outstanding for the issuer and indicates an approximate sale date of 01/05/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
other
Rhea-AI Summary

Leonardo DRS (DRS) reported an insider transaction by a director. On 11/13/2025, the reporting person disposed of 2,600 shares of common stock as a gift (transaction code G) at $0 per share. Following this transaction, the reporting person beneficially owns 27,720 shares, held directly. The filing was made by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Leonardo DRS (DRS) reported strong Q3 2025 results. Revenue reached $960 million, up 18% year over year, with diluted EPS of $0.26 and net earnings of $72 million. Operating earnings were $93 million as gross margin improved to 23.1% from 22.0%.

Year to date, revenue was $2.588 billion (up 15%) and diluted EPS was $0.65. Backlog totaled $8.909 billion as of September 30, 2025, and Q3 bookings were $1.307 billion. Segment revenue was $580 million for Advanced Sensing & Computing and $383 million for Integrated Mission Systems.

Cash and equivalents were $309 million, with total debt of $350 million and no borrowings on the $275 million revolver. Net cash used in operating activities was $59 million for the first nine months. The company repurchased $24 million of stock under a $75 million program and paid $0.27 per share in dividends year to date; a $0.09 per share dividend was declared for payment on December 2, 2025. Subsequent to quarter end, John Baylouny was appointed President & CEO effective January 1, 2026; Frances F. Townsend will become Board Chair the same day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.36%
Tags
quarterly report
-
Rhea-AI Summary

Leonardo DRS (DRS) announced a planned CEO transition. William J. Lynn III will retire as Chief Executive Officer, Non-Proxy Holder Director, and Chairman effective at midnight on December 31, 2025, and remain an employee through April 1, 2026. The Board appointed John Baylouny as President and Chief Executive Officer, and as a Non-Proxy Holder Director, effective January 1, 2026.

The company entered into an employment agreement with Mr. Baylouny providing a 2026 base salary of $950,000, a target annual incentive equal to 120% of base salary (maximum 200% of target), and a 2026 long‑term incentive target of $2,500,000 under the 2022 Omnibus Equity Compensation Plan. If terminated by the company other than for cause, he is eligible for a lump sum equal to two times base salary, specified bonus components, continued vesting treatment on equity awards, and up to 18 months of COBRA and welfare benefits.

The Board also appointed Frances F. Townsend as Chair effective January 1, 2026. A news release covering these changes was furnished under Item 7.01.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.36%
Tags
current report
Rhea-AI Summary

Leonardo DRS, Inc. furnished an update on its business by issuing a news release reporting financial results for the third quarter ended September 30, 2025, via an 8-K under Item 2.02.

Management plans to discuss operations and results on an earnings conference call at 9:30 a.m. Eastern Time on October 29, 2025, with a live audio webcast and supplemental presentation available through the Investor Relations website. The materials are furnished, not filed, and the news release is attached as Exhibit 99.1.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.36%
Tags
current report
-
Rhea-AI Summary

Leonardo DRS (DRS) reported an insider transaction by its EVP and COO. On October 15, 2025, the reporting person sold 8,481 shares of common stock at $43.69 per share under a Rule 10b5-1 trading plan.

Following the sale, the reporting person beneficially owns 106,007 shares directly. The trading plan was adopted on May 13, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

John Baylouny, Executive Vice President and Chief Operating Officer of Leonardo DRS, reported a planned sale of company stock. On 09/17/2025 he disposed of 11,420 shares of common stock at $41.78 per share under a pre-established Rule 10b5-1 trading plan adopted May 13, 2025. Following the sale, the filing shows he beneficially owns 114,488 shares, held directly. The report was signed by attorney-in-fact Katherine Krebel on 09/18/2025. The Form 4 records a routine, prearranged insider sale rather than an open-market discretionary trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

An individual related to Leonardo DRS (DRS) notified the market of a proposed sale of 11,420 common shares with an aggregate market value of $477,127.60, scheduled for 09/17/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 03/15/2024 and were received as compensation.

The filing also reports that the same person sold 11,375 shares on 08/20/2025 for gross proceeds of $468,308.75. The notice includes a representation that the seller does not possess undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Leonardo DRS (DRS)?

The current stock price of Leonardo DRS (DRS) is $46.58 as of March 6, 2026.

What is the market cap of Leonardo DRS (DRS)?

The market cap of Leonardo DRS (DRS) is approximately 12.2B.

DRS Rankings

DRS Stock Data

12.18B
75.38M
Aerospace & Defense
Search, Detection, Navigation, Guidance, Aeronautical Sys
Link
United States
ARLINGTON

DRS RSS Feed